These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8200229)
1. Relationship among p53, stage, and prognosis of large bowel cancer. Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229 [TBL] [Abstract][Full Text] [Related]
2. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282 [TBL] [Abstract][Full Text] [Related]
3. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma. Suzuki H; Matsumoto K; Koide A; Tada T; Fujino I; Okuda A; Shigemori C Surg Today; 1994; 24(1):85-7. PubMed ID: 8054784 [TBL] [Abstract][Full Text] [Related]
4. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas. Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462 [TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena. Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699 [TBL] [Abstract][Full Text] [Related]
8. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer. Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497 [TBL] [Abstract][Full Text] [Related]
9. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1). Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199 [TBL] [Abstract][Full Text] [Related]
10. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. Borre M; Stausbol-Gron B; Overgaard J J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma. Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958 [TBL] [Abstract][Full Text] [Related]
12. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268 [TBL] [Abstract][Full Text] [Related]
13. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas. Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475 [TBL] [Abstract][Full Text] [Related]
14. [Variation in the prognostic value of p53 protein in relation to tumoral stage in patients with colorectal adenocarcinoma]. Díez M; Pollán M; Ramos P; Villeta R; Ratia T; Hernández P; Lozano O; Noguerales F; Granell J Cir Esp; 2005 Apr; 77(4):213-20. PubMed ID: 16420920 [TBL] [Abstract][Full Text] [Related]
15. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head. Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma. Zhang Hong Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350 [TBL] [Abstract][Full Text] [Related]
17. [P53 protein in adenocarcinoma of the large intestine]. Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410 [TBL] [Abstract][Full Text] [Related]
19. Mutant p53 protein as a predictor of survival in endometrial carcinoma. Strang P; Nordstöm B; Nilsson S; Bergström R; Tribukait B Eur J Cancer; 1996 Apr; 32A(4):598-602. PubMed ID: 8695259 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. Williams DS; Mouradov D; Browne C; Palmieri M; Elliott MJ; Nightingale R; Fang CG; Li R; Mariadason JM; Faragher I; Jones IT; Churilov L; Tebbutt NC; Gibbs P; Sieber OM Mod Pathol; 2020 Mar; 33(3):483-495. PubMed ID: 31471586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]